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Asthmatic airways are infiltrated with inflammatory cells that release mediators and cytokines into
the microenvironment. In this study, we evaluated the distribution of CD45-positive leukocytes and
eosinophils in lung tissue from five patients who died with severe asthma compared with five pa-
tients with cystic fibrosis. For morphometric analysis, the airway wall was partitioned into an “inner”
area (between basement membrane and smooth muscle) and an “outer” area (between smooth
muscle and alveolar attachments). Large airways (with a perimeter greater than 3.0 mm) from pa-









 0.001) in the inner airway region compared with the same airway region in small airways.








 0.01) in the outer compared with the inner airway wall region. These ob-
servations indicate that there are regional variations in inflammatory cell distribution within the air-
way wall in patients with asthma that are not observed in airways from patients with cystic fibrosis.
We speculate that this inflammatory cell density in peripheral airways in severe asthma may relate to
the peripheral airway obstruction characteristic of this condition. 
 
Haley KJ, Sunday ME, Wiggs BR,










cell distribution within and along asthmatic airways.
 
AM J RESPIR CRIT CARE MED 1998;158:565–572.
 
Histopathologic studies of airways from patients with asthma
have established that asthma is a process involving the entire
bronchial tree, which includes infiltration of the airway wall
with inflammatory cells and thickening of all components of
the airway wall (1–11). Among the critical findings in such
studies has been an appreciation of the importance of histo-
pathologic changes in peripheral airways with respect to the
observed physiologic changes in asthma (1, 4, 5, 7, 9, 12–14).
Investigations examining the peripheral cellular infiltrates in
fatal asthma have demonstrated abundant inflammatory cells
in the lung periphery (6, 9, 13, 15). Additional studies have
compared the areas of airway wall subdivisions in asthma (1,
12, 14), and have compared the epithelial inflammation with
the remainder of the airway wall (15). However, they do not
detail the location of the inflammatory infiltrate within the
subepithelial portion of the airway wall, or whether the loca-
tion of the inflammatory infiltrate within the subepithelial
portion of the airway wall differs between the large and small
airways. The goal of this study was to address these unan-
swered questions of whether there are differences in the in-
flammatory infiltrate within the subepithelial regions of the
airway wall and whether the patterns of inflammatory cells
differ between large and small airways.
Evaluating such differences might be informative for sev-
eral reasons. If the histopathology of the inflammatory infil-
trate differs within the subepithelial component of the airway
wall in large and small airways, such differences could poten-
tially result in varying response to stimuli in airways of differ-
ent sizes. Alternatively, if the inflammatory infiltrate varies
within the airway wall, local gradients of inflammatory media-
tors could occur that might influence the response of airway
wall components to a phlogistic environment. In particular,
many of the mediators associated with asthma such as leuko-
trienes (16), tumor necrosis factor (17, 18), neuropeptides (19–
21), purines (22), prostaglandins (23), and eotaxin (24) are
rapidly inactivated, and so would be expected to act only
ephemerally in the microenvironment. Therefore, regional dif-
ferences in inflammatory cell density could have important
implications for the pathobiology of asthma.
Because the distribution of the inflammatory infiltrate both
within the airway wall and between the central and peripheral
airways of asthmatics has not been established, we examined
the distribution of leukocytes, identified by immunostaining as
expressing the pan-leukocyte marker CD45 antigen (leuko-
cyte common antigen), as well as eosinophils, in central and
peripheral airways of patients who died with or as a result of
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ysis of lungs removed from patients with another chronic in-
flammatory lung disease, cystic fibrosis. We chose cystic fibro-
sis as an example of severe, chronic airway inflammation
having an etiology distinct from asthma. The use of samples
from these two syndromes allowed us to compare chronic pul-
monary inflammation affecting both the large and the small
airways, but which resulted from different pathophysiologic
stimuli. Our data indicate that there are distinct distributions







Pathology records from the Children’s Hospital and Brigham and
Women’s Hospital were reviewed to identify all postmortem exami-
nations that listed asthma as the primary or major contributing cause
of death. Autopsy tissue from patients whose cause of death as identi-





or having asthma listed as one of the primary diagnoses contributing




 1) was identified. In addition, surgical spec-




5) were identified from pathology records as well as five cases in
which cystic fibrosis was listed as the primary cause of death. The sam-
ples from cystic-fibrosis-related deaths were used to evaluate whether
the patterns of inflammatory cells were different in autopsy samples
from those in surgical samples. This evaluation was qualitative and
served only to confirm that the patterns of inflammatory cells could
be expected to remain approximately stable in postmortem speci-
mens. The paraffin tissue blocks were screened using a hematoxylin-
eosin stain to identify the presence of suitable airways for each case.
On the basis of this review, between one and three blocks were chosen
from each case. From these materials, histologic sections, five microns
thick, were cut from formalin-fixed paraffin-embedded tissue blocks.





Serial tissue sections were stained with Masson’s trichrome for iden-
tification of smooth muscle, with hematoxylin-eosin (H and E) for
identification of eosinophils, and by immunostaining using a murine
monoclonal anti-CD45 antibody to identify leukocytes. A modified
avidin-biotin complex (ABC) technique (25) was used for CD45 iden-
tification. The sections were dewaxed in xylenes, rehydrated in etha-
nol, and incubated in a microwave oven on high power for 30 s. Non-
specific immunoglobulin binding was blocked with 10% normal horse





, Dako clones 2B11 and PD7/26; Dako Corp., Carpinte-




g/ml in phosphate-buffered saline with 2%





 C overnight in a humidified chamber; negative con-




 MOPC-21 (Sigma Chemical




g/ml, were incubated in the same
fashion. The sections were incubated with the secondary antibody, a
biotinylated horse antimouse IgG (Vector Laboratories, Burlingame,









 C for 2 h. Endogenous peroxidase activity was subsequently
quenched using methanol containing 1% hydrogen peroxide. ABC
standard (Vector Laboratories) was made according to the manufac-
turer’s instructions, applied to sections, and incubated at room tem-
perature for 1 h. Immunopositivity was localized using the chromagen
diaminobenzidine (0.025% wt/vol) in PBS and 0.1% hydrogen perox-
ide. The internal positive control consisted of prominent alveolar
macrophage staining. Masson’s trichrome stain was carried out ac-
cording to the manufacturer’s instructions (Sigma). To better demon-
strate eosinophils, H and E staining was performed with the addition




Morphometry was performed using a Nikon microscope equipped




200, a cursor was projected
onto the microscopic field and the images were outlined onto a digitiz-
ing pad interfaced with a computer running morphometry software
(SigmaScan; Jandel Scientific, San Rafael, CA). The trichrome stain
was used to locate smooth muscle boundaries. In each section, all air-
ways demonstrating smooth muscle surrounding at least 50% of the
perimeter and having well-demarcated alveolar attachments were
included in morphometric analysis. The airway size was determined
by both histologic criteria and basement membrane perimeter (27),
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large cystic fibrosis airways) had ciliated columnar epithelium, and
most contained cartilage or were visible to the unaided eye; these air-
ways had perimeter lengths from 3.0 to 21.9 mm. Three of the five
asthmatic cases had large airways suitable for LCA and H and E mor-
phometric analysis, with the number of airways per case ranging from
two to nine. Four of the five cystic fibrosis cases had large airways
suitable for LCA morphometric analysis, with the number of airways
per case ranging from one to three. Three of the five cystic fibrosis
cases had large airways suitable for H and E morphometric analysis,
with the number of airways per case ranging from one to three. Small


















 11 cystic fibrosis small airways) were defined as muscular
membranous bronchioles; in addition, any airway with cuboidal epi-
thelium was defined as “small.” The small airways had perimeter
lengths from 0.2 mm to 3.6 mm. All the asthmatic small airway perim-
eters were less than or equal to 3.0 mm. One of the cystic fibrosis
small airways demonstrated cuboidal epithelium, and was classified as
“small,” even though its perimeter was 3.6 mm; the remaining 10 small
cystic fibrosis airways all had perimeters less than 3.0 mm. All of the
asthmatic cases had small airways suitable for LCA and H and E mor-
phometric analysis, with the number of airways per case ranging from
five to 11. Four of the five cystic fibrosis cases had small airways suit-
able for LCA and H and E morphometric analysis, with the number of
airways per case ranging from one to seven.
For purposes of cell counting, the airway wall cross section was
subdivided into two regions: one was defined as the “inner” area and
contained the distal edge of the basal lamina to the luminal edge of
the smooth muscle, whereas the “outer” area was defined as the re-
gion from the outer edge of the smooth muscle to the alveolar attach-
ments (Figure 1). These areas were outlined by projecting a cursor
onto the microscopic field by means of a drawing tube. In areas where
the muscle was discontinuous, the approximate site of the muscle
boundary was extrapolated by visually connecting two adjacent mus-
cle bundles with a straight line. In cartilaginous airways, the area oc-
cupied by cartilage was excluded. Elements of the airway wall such as
mucous glands and their associated inflammatory cells were included
in area and cell count analyses; cells inside capillaries contained in the
airway wall were excluded from analyses. Two to three nonadjacent
wedge-shaped segments were counted for each airway, which were
approximately evenly spaced around the airway (that is, at 2, 6, and 10
o’clock); to be eligible for morphometric analysis, a segment had to
have both “inner” and “outer” areas. After the segments and areas
were delineated, the inflammatory cells (CD45-positive cells or eosi-
nophils) were counted. Cell densities were calculated, and expressed
as the number of cells per square millimeter tissue. The use of cell
density per square millimeter tissue allowed the inflammatory infil-




The data analysis for this study required a method of comparing mul-
tiple factors (“inner” density, “outer” density, and the difference be-
tween “inner” and “outer” densities) in different sized airways (large
and small) in two diagnoses (cystic fibrosis and asthma). We found
that a two-way ANOVA, nested for diagnosis, provided the best
model for this analysis. A further advantage of this technique was that
it allowed comparison of different numbers of airways between diag-





error of the mean (SEM). Differences were accepted as statistically















Clinical Characteristics and Pathologic Features
 
The clinical characteristics of the patients studied are pro-
vided in Table 1; the average age for both groups was similar:
28.2 yr (range, 5 to 56 yr) for the asthmatics and 28.0 yr (range,
23 to 31 yr) for the patients with cystic fibrosis. Two of the pa-
tients with asthma and one of the patients with cystic fibrosis
were receiving steroids chronically (oral or inhaled), two asth-
matic patients and four patients with cystic fibrosis did not re-
ceive steroids regularly (there was no available information
about steroid use for one of the asthmatic patients). All asth-
matic patients received steroids during their hospital course.
The duration of the final illness in the asthmatics ranged from
less than 24 h to 25 d. Record review indicated that none of
the patients in either group used tobacco products.
Review of the H and E staining confirmed histology consis-
tent with the previously assigned diagnoses in all cases. The
asthmatic inflammatory infiltrates demonstrated a mixed cel-
lularity composed of lymphocytes, eosinophils, macrophages,
and neutrophils. The cystic fibrosis infiltrates consisted pre-
dominantly of neutrophils with scattered eosinophils noted in
the cartilaginous airways. The pattern of inflammatory cell
infiltration did not differ qualitatively between the samples
of cystic fibrosis lung obtained from autopsy and the surgical




All the samples from asthmatic subjects demonstrated a
prominent inflammatory cell infiltrate surrounding cartilagi-
nous and membranous airways; however, there were substan-
tial differences in the location of these infiltrates within the
large and small airways and within the airway wall (Figure 2
and Table 2). Compared with the small airways (Figure 2B),




0.05) density of CD45-positive cells in the “inner” airway wall
(Table 2). However, the density of CD45-positive cells located
in the “outer” airway wall region was not statistically different
between the large and small airways (Table 2). Within large
airways, the CD45-positive cells were located in both the
“inner” and the “outer” airway regions (Table 2). The small





 0.01) density of CD45-positive cells in the “outer”
versus the “inner” region (Figure 2B and Table 2). Further-
more, comparison of the differences between the “inner” and
“outer” regions in the large versus the small airways demon-




 0.05) difference in the location of the
inflammatory infiltrate in the large and small airways (Figure
3A), with a predominantly “outer” infiltrate in the small air-
ways. No differences in patterns were observed in airways ob-
tained from subjects with and without a history of chronic ste-
roid use (data not shown).
Lungs from subjects with cystic fibrosis demonstrated
CD45-positive cells infiltrating both the large and the small air-
ways, with CD45-positive cells found in both the “inner” and
the “outer” regions in large and small airways (Figures 2C and
2D). Compared with the small airways, the large airways had a
significantly greater density of CD45-positive cells in the “in-




 0.05) (Table 2). In contrast to the
asthmatic samples, there were no significant differences be-
tween the densities of the CD45-positive cells in the “inner”
and “outer” airway wall regions in either the large or the small
airways (Figure 3A). In order to facilitate comparisons, the
“inner” airway wall inflammatory cell density in airways from
cystic fibrosis lungs were matched to asthmatic airways. In
these samples, the differences in CD45-positive cell distribu-
tion between the cystic fibrosis and asthmatic airways per-
sisted. That is, in these airways matched for “inner” airway
wall region cell densities, the cystic fibrosis small airways did
not demonstrate significant differences in the density of CD45-
positive cells between the “inner” and “outer” regions. How-
ever, the asthmatic small airways demonstrated an “outer” re-




The density of the eosinophilic infiltrates also varied with both
airway size and location within the airway wall (Table 3).
Within the “inner” region of the airway wall, there was a sig-
 
TABLE 1
CLINICAL CHARACTERISTICS OF SUBJECTS WITH
ASTHMA AND CYSTIC FIBROSIS
 
Diagnosis Age Sex Duration of Acute Symptoms Chronic Steroids
Asthma 56 F 26 d No




 24 h No




 24 h Yes
Asthma (status) 14 M 2 d Yes




 24 h Unknown
Cystic fibrosis 30 M Not applicable No
Cystic fibrosis 31 M Not applicable No
Cystic fibrosis 31 F Not applicable Yes
Cystic fibrosis 23 F Not applicable No
Cystic fibrosis 25 F Not applicable No
Figure 1. Schematic drawing of “inner” and “outer” airway wall
regions. The “inner” region of the airway is defined as the area be-
tween the basement membrane and the smooth muscle, and the
“outer” region of the airway is defined as the area between the
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nificantly greater density of eosinophils in the large versus the




 0.001). In contrast, the “outer”
airway wall region did not demonstrate significant differences
in eosinophil density between the large and the small airways
(Table 3). Within the large asthmatic airways a significantly
greater density of eosinophils was found in the “inner” region




 0.01). In contrast, in
small asthmatic airways there was an “outer” eosinophil distri-
bution (i.e., significantly more cells per area in the “outer” than




 0.01). The difference in cell den-
sity between the “inner” and “outer” regions in the large ver-




 0.001) (Figure 3B).
In airways from patients with cystic fibrosis, there were
only scattered eosinophils that were predominantly associated
with large rather than small airways (Table 3). The distribu-
tion of this cell type did not vary significantly within the air-
way wall in either the large or the small airways. There were
nonsignificant trends for the densities of eosinophils to be









 0.081) compared with the




Our data demonstrate that the distribution of CD45-positive
cells and eosinophils within the airway wall varies significantly
between large and small asthmatic airways. The small asth-
matic airways had a preponderance of their inflammatory
cells, including eosinophils in particular, in the “outer” region,
whereas the greatest density of eosinophils in the large asth-
matic airways was in the “inner” region. Airways from pa-
tients with cystic fibrosis demonstrated a different pattern of
inflammatory cells. The density of the CD45-positive cells in
the small cystic fibrosis airways did not vary between the “in-
ner” and the “outer” regions.
Figure 2. Immunostaining for CD45. (A) Large asthmatic airway. (B) Small asthmatic airway, demonstrating “outer” pattern of inflamma-
tory cell distribution. (C) Large cystic fibrosis airway. (D) Small cystic fibrosis airway demonstrating uniformly distributed CD45-positive
cells. Original magnification 3250. AL 5 airway lumen; E 5 epithelium; SM 5 smooth muscle.
 
TABLE 2
VARIATION IN CD45-POSITIVE CELLS WITH
































































































* Designates large airway “inner” airway wall density greater than small airway “in-
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One of the most important aspects of this study was the use
of surgical and autopsy specimens, which allowed us to sample
both the large and small airways and to examine the inflam-
matory infiltrate throughout the entire airway circumference
instead of limiting analyses to the subepithelial area obtained
by endobronchial biopsy. Although the data from endobron-
chial biopsy and bronchoalveolar lavage studies have yielded
insights into the immunologic mechanisms of asthma, these
sampling techniques are limited. Neither technique samples
the entire airway wall, and only cartilaginous bronchi are ac-
cessible to endobronchial biopsies. Our data indicate that leu-
kocyte types and densities in the central subepithelial regions
cannot be extrapolated either to deeper areas of the airway
wall or to the peripheral bronchioles, and that endobronchial
biopsies of more peripheral airways may not sample an “outer”
infiltrate.
However, the use of archival autopsy and surgical speci-
mens also imposed several limitations on this study. In partic-
ular, we were not able to control the tissue fixation in the sam-
ples, and frequently had only a limited number of airways to
evaluate from each case. The differences in cell fixation may
have led to case-to-case variation in immunostaining sensitiv-
ity; however, comparing the staining to an internal positive
control (alveolar macrophage staining) minimized this prob-
lem. Qualitative comparison of the surgical and autopsy speci-
mens from cystic fibrosis lung did not demonstrate any differ-
ences in inflammatory cell patterns. Therefore, it is likely that
the differences observed in this study were due to the disease
processes rather than to the use of surgical and autopsy tissue.
We maximized the number of airways suitable for morpho-
metric analysis by evaluating cell densities per square millime-
ter of tissue.
The results of this study support and extend previous inves-
tigations examining the differences between large and small
airways as well as the prominent small airway changes in fatal
asthma. Several investigative groups have shown that the thick-
ening of the airway wall components can be demonstrated in
airways of all sizes (1, 3, 7, 9, 11, 13). Carroll and colleagues
(1), comparing lungs from patients with fatal and nonfatal
asthma with lungs from normal control subjects, demonstrated
that the relative changes in the airway wall components varied
with the size of the airway examined. In this study, the carti-
laginous airways from nonfatal asthmatic samples were similar
to control lung tissue in total airway wall thickness and area of
smooth muscle. However, the area including the outer border
of the smooth muscle and the epithelium, designated as the in-
ner area, was larger in the nonfatal asthmatic lung tissue sam-
ples than in the control samples in airways with basement
membrane perimeters less than 10 mm. In addition, the air-
ways with basement membrane perimeters between 10 and 18
mm demonstrated increased inner wall thickness in the tissue
from patients with fatal versus those with nonfatal asthma.
James and colleagues (13), using observed changes in airway
wall thickness, demonstrated that the same degree of smooth
muscle shortening resulted in approximately tenfold greater
increases in airway resistance in small membranous airways
Figure 3. Differences between the “inner” and “outer” inflammatory cell densities, where regions with equivalent cell densities would
yield a difference of zero; positive values indicate greater “inner” region density, and negative values indicate greater “outer” region den-
sity. (A) CD45-positive inflammatory cells. (B) Eosinophils. *Designates a statistically significant difference at p , 0.01 compared with zero.
†Designates a statistically significant difference at p , 0.05 comparing large and small airways. ‡Designates a statistically significant differ-
ence at p , 0.001 comparing large and small airways. Bars indicate one standard error of the mean. Abbreviations: cf 5 cystic fibrosis; lg 5
large airway; sm 5 small airway.
 
TABLE 3
VARIATION IN EOSINOPHIL DENSITY WITH




































































































* Designates large airway “inner” airway wall density greater than small airway “in-








 Designates large airway “inner” wall eosinophil density significantly greater than








 Designates small airway “outer” eosinophil density significantly greater than small
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compared with cartilaginous airways. These anatomic changes
may be related to physiologic changes. Lambert and colleagues
(29) used a computer model to differentiate the relative con-
tributions of increases in the submucosal, smooth muscle, and
adventitial airway subdivisions with regard to airway constric-
tion. These investigators identified different mechanisms for
airway narrowing depending on the airway wall region. Changes
in the submucosa led to increased lumenal occlusion for any
amount of muscle shortening, whereas increases in the adven-
titia promoted airway constriction by decreasing the tethering
effects of the parenchyma (29).
The components of the peripheral inflammation in fatal
asthma have been detailed by many investigators (2, 5, 6, 8, 9,
15, 30, 31). These studies have shown that the peripheral air-
ways in fatal asthma have an abundant inflammatory infiltrate
(2, 5, 6, 9, 15, 30, 31). In addition, several investigators have re-
ported that the pathology found in the membranous bron-
chioles frequently differs from that in the large airways (2,
5), with the small bronchioles frequently demonstrating air-
way distention instead of constriction. A recent investigation
by Synek and colleagues (15), examining specimens obtained
from patients with nonfatal and fatal asthma, compared the in-
filtrates identified in airway epithelium with those in the air-
way wall as a whole. This study found that, compared with
those in mild asthma, the infiltrates associated with fatal asthma
demonstrated fewer intraepithelial T-lymphocytes and more
eosinophils throughout the airway wall in the larger airways,
but no differences were observed between the two types of
asthma in the small membranous bronchioles (15). In contrast,
a recent study by Carroll and colleagues (31), which examined
tissue from patients with fatal asthma, nonfatal asthma, and
control patients, demonstrated an increased number of eosi-
nophils in the airway walls from fatal asthma in all airway
sizes. This study did not subdivide the peripheral airway wall,
and found similar overall densities in the peripheral airways
compared with the area in the larger airways between the
basement membrane and the outer border of the smooth mus-
cle (31).
The current study did not quantitate epithelial inflamma-
tion because of frequent disruption of the epithelial surface in
our samples. Instead, our study focused on the location of in-
flammatory infiltrates within the subepithelial regions of the
airway wall and demonstrated that the density of the inflam-
matory infiltrates was a function of both the location within
the airway wall and airway size. Therefore, it is important to
consider the various compartments within the airway wall
since such an analysis may reveal variations in cell density
within the airway wall in a given size airway that might not
otherwise be apparent.
The cell densities in the current study are higher than those
reported by Synek and colleagues (15). However, a broad
range of cell densities in fatal asthma have been documented
in the literature (15, 30–34). These variations in cell densities
have been found in studies that used either cells per millime-
ter basement membrane (31–34) or cells per square millimeter
tissue (15, 30) as a basis of quantitation of the inflammatory
infiltrate. We measured the inflammatory infiltrate using cells
per square millimeter tissue. We report cell densities that are
in the ranges previously reported by Poston and colleagues
(35) in asthmatic airways and Faul and colleagues (30) in fatal
asthma. Importantly, others have not examined the distribu-
tion of this infiltrate within the compartments of the airway
wall in asthmatics.
The investigation of Azzawi and colleagues (34) also com-
pared airways from asthmatic patients to airways from pa-
tients with cystic fibrosis. These investigators examined total





m deep to the basement membrane in airways with a di-
ameter between 0.5 and 1.5 cm, and they documented an abun-
dant inflammatory infiltrate with both lymphocytes and eosi-
nophils in samples from both the patients with cystic fibrosis
and the asthmatics (34). Our data agree with the findings of
the previous investigation regarding the large airway inflam-
matory cells. In addition, by extending the examination to the
smaller airways, our study suggests that the two inflammatory
processes may demonstrate a different pattern of cellular re-
cruitment in the periphery: the “outer” pattern of infiltrate
found in the asthmatic small airways was not observed in the
cystic fibrosis small airways.
The variation in inflammatory cell density seen in the air-
ways of patients with asthma, but not in those of patients with
cystic fibrosis, suggests that this “inner” versus “outer” pat-
tern is not part of a generalized, nonspecific pulmonary in-
flammatory response but may rather be related to the biology
of these disorders. The difference between the localization of
inflammatory cells in asthmatic and cystic fibrosis airways per-
sisted when subjects were matched for “inner wall” densities.
That is, even in airways matched for the “inner wall” densities,
the asthmatic small airways demonstrated an “outer” pattern
of inflammatory cells that was not observed in cystic fibrosis
small airways. This suggests that the localization patterns were
due to other factors besides the cell density of the peribronchi-
olar infiltrate.
Thus, the patterns of the observed inflammatory cell infil-
tration must result from differences in cell recruitment, reten-
tion, or microenvironmental viability. Several factors could
have a role in producing these differences. First, the large and
small airways differ in their blood supply. The inner regions of
the large airways are supplied by the bronchial circulation,
whereas the outer airway wall and the small airways are sup-
plied by the pulmonary circulation (36). It is possible that
these vessels may have distinctive expression of endothelial
adhesion molecules that, in turn, could promote different pat-
terns of inflammatory cell distribution. Second, the cytokine
profile produced by local cells within the airway wall and lu-
men might vary within regions of the airway or size of airway,
resulting in the observed differences in patterns of inflamma-
tory cell density. In addition to the large number of cytokines
and chemokines known to be produced by the resident inflam-
matory cells, pulmonary epithelial cells have been documented
to produce chemoattractants such as interleukins 6 and 8, eo-
taxin, RANTES, and the eicosanoids (24, 37–40). Because the
capacity to produce these molecules is modulated by cyto-
kines in the microenvironment, it seems reasonable to specu-
late that there could be spatial differences within and among
the various airways in patients with asthma with respect to the
formation of these cytokines. Third, another possible mecha-
nism of differential recruitment relates to the variation in the
innervation of the proximal and distal airways (19). This could
result in regional differences in responses to those stimuli hav-
ing effects through inflammatory mediators, including cytokines
and chemokines, as well as through activation of nonadrener-
gic-noncholinergic nerves, leading to the release of neuro-pep-
tides such as tachykinins.
The difference in the pattern of inflammatory cell infil-
trates in the lungs affected by asthma compared with cystic fi-
brosis could be due to differences in the initiating stimulus or
to variations in the resulting chemoattractant responses. For
example, in advanced cystic fibrosis, the major stimulus to air-
way inflammation is bacterial infection, provoking a neutro-
phil-predominant infiltrate, whereas in asthma, a number of
etiologic stimuli have been proposed that evoke the inflamma-
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tory response unique to that condition (41, 42). The different
spatial organization of inflammatory patterns suggests that
there is regional organization of pulmonary inflammation, and
that this organization is disease-specific.
The functional consequences of the observed variation in
inflammatory cell pattern remain speculative. The variations
could influence the physiologic effects caused by local produc-
tion of proinflammatory mediators by inflammatory cells and
eosinophils. For example, factors elaborated immediately next
to smooth muscle are likely to exert a greater effect than prod-
ucts that must diffuse through the connective tissue of the air-
way wall. Furthermore, the microenvironment of the airway
wall could modify the response of functional elements such as
smooth muscle or mucous glands to growth factors or cyto-
kines. Understanding the mechanism of differential distribu-
tion of inflammatory cells and evaluating their functional sig-
nificance remain important unexplored areas to investigate in
the pathogenesis of asthma.
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